Clinical Trials Directory

Trials / Completed

CompletedNCT00589511

Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study

Status
Completed
Phase
Study type
Observational
Enrollment
69 (actual)
Sponsor
Cochlear · Industry
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

The objective of this multisite study is to evaluate the performance of the Nucleus Freedom cochlear implant system in a large population of sequentially implanted pediatric subjects.

Detailed description

The proposed study will include 50 pediatric subjects ages 1 year to 17 years, 11 months of age, implanted at up to 5 sites in the United States and Canada. The estimated duration of this multisite study is 18 to 24 months. The duration of individual subject participation is not to exceed 12 months. The study will be conducted as a within-subject repeated measures experiment (in which each subject serves as his or her own control) in order to accommodate the heterogeneity that is well known to characterize hearing-impaired populations

Conditions

Timeline

Start date
2006-10-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2008-01-09
Last updated
2014-08-11

Source: ClinicalTrials.gov record NCT00589511. Inclusion in this directory is not an endorsement.